Taiwan FDA registration 9cd3982b4759b46768f5f996d3815088

BD FC Microbeads Trial

TW: BD FC 微珠試劑組

Taiwan·Risk Class 2·Becton, Dickinson and Company, BD Biosciences;; Becton, Dickinson Caribe, Ltd.·Registered Jan 31, 2024 – Jan 31, 2029Active

Registration details

Analysis ID: 9cd3982b4759b46768f5f996d3815088
Customs Code: DHA05603705709

Company information

Manufacturer: Becton, Dickinson and Company, BD Biosciences;; Becton, Dickinson Caribe, Ltd.
Manufacturer Country: United States
Authorized Representative: BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)

Product details

Intended Use: This product is designed to establish fluorescence compensation on the BD FACSLyric Flow Cytometer.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.5220 Automatic Differentiation Cell Counter
Import Information: QMS/QSD;; 輸入

Dates and status

Registration Date: Jan 31, 2024
Expiry Date: Jan 31, 2029

About this record

Access comprehensive regulatory information for BD FC Microbeads Trial in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9cd3982b4759b46768f5f996d3815088 and manufactured by Becton, Dickinson and Company, BD Biosciences;; Becton, Dickinson Caribe, Ltd.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.